We are live on ! Find out more
LC

Lindbrook Capital Portfolio holdings

AUM $1.08B
1-Year Est. Return 10.14%
This Fund
S&P 500
This Quarter Est. Return
+7.83%
1 Year Est. Return
+10.14%
3 Year Est. Return
+35.77%
5 Year Est. Return
+141.26%
10 Year Est. Return
AUM
$853M
AUM Growth
+$41.2M
Cap. Flow
-$4.27M
Cap. Flow %
-0.5%
Top 10 Hldgs %
45.97%
Holding
2,993
New
166
Increased
1,040
Reduced
961
Closed
220

Sector Composition

Rank Sector Weight
1 Financials 17.04%
2 Technology 13.3%
3 Healthcare 7.37%
4 Industrials 3.43%
5 Consumer Staples 3.24%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
TPC
1651
Tutor Perini Cor
TPC
$5.21B
$7.32K ﹤0.01%
1,187
-24
-2% -$193
BE icon
1652
Bloom Energy
BE
$64.6B
$7.31K ﹤0.01%
367
-124
-25% -$2.71K
KTOS icon
1653
Kratos Defense & Security Solutions
KTOS
$11.4B
$7.31K ﹤0.01%
542
+96
+22% +$1.15K
CVAC
1654
DELISTED
CureVac
CVAC
$7.3K ﹤0.01%
1,048
+250
+31% +$2.18K
CDNA icon
1655
CareDx
CDNA
$2.42B
$7.3K ﹤0.01%
799
+778
+3,705% +$9.95K
ENS icon
1656
EnerSys
ENS
$6.99B
$7.3K ﹤0.01%
84
SMMT icon
1657
Summit Therapeutics
SMMT
$11.1B
$7.29K ﹤0.01%
4,166
+3,870
+1,307% +$10.6K
AVID
1658
DELISTED
Avid Technology Inc
AVID
$7.29K ﹤0.01%
228
ATNI icon
1659
ATN International
ATNI
$492M
$7.28K ﹤0.01%
+178
New +$7.86K
ABM icon
1660
ABM Industries
ABM
$2.84B
$7.28K ﹤0.01%
162
BUSE icon
1661
First Busey Corp
BUSE
$2.56B
$7.26K ﹤0.01%
357
+100
+39% +$2.33K
USPH icon
1662
US Physical Therapy
USPH
$1.22B
$7.25K ﹤0.01%
74
-2
-3% -$191
HOUS
1663
DELISTED
Anywhere Real Estate
HOUS
$7.23K ﹤0.01%
1,370
+1,277
+1,373% +$8.7K
NBHC icon
1664
National Bank Holdings
NBHC
$1.9B
$7.23K ﹤0.01%
216
TGI
1665
DELISTED
Triumph Group
TGI
$7.2K ﹤0.01%
621
+391
+170% +$4.45K
GIC icon
1666
Global Industrial
GIC
$1.49B
$7.19K ﹤0.01%
268
VSH icon
1667
Vishay Intertechnology
VSH
$5.43B
$7.19K ﹤0.01%
318
+27
+9% +$593
SAVE
1668
DELISTED
Spirit Airlines, Inc.
SAVE
$7.16K ﹤0.01%
417
+405
+3,375% +$7.57K
TMHC
1669
DELISTED
Taylor Morrison
TMHC
$7.16K ﹤0.01%
187
+9
+5% +$316
ZNTL icon
1670
Zentalis Pharmaceuticals
ZNTL
$302M
$7.16K ﹤0.01%
416
+408
+5,100% +$8.26K
FLR icon
1671
Fluor
FLR
$7.96B
$7.14K ﹤0.01%
231
-118
-34% -$4.06K
DVAX
1672
DELISTED
Dynavax Technologies
DVAX
$7.13K ﹤0.01%
727
-38
-5% -$406
HEZU icon
1673
iShares Currency Hedged MSCI Eurozone ETF
HEZU
$586M
$7.13K ﹤0.01%
226
CPT icon
1674
Camden Property Trust
CPT
$11.3B
$7.13K ﹤0.01%
68
+2
+3% +$228
LIVN icon
1675
LivaNova
LIVN
$4.2B
$7.1K ﹤0.01%
163
+90
+123% +$4.56K

Similar funds

Lindbrook Capital's Q1 2023 Portfolio in Review

As of Q1 2023, Lindbrook Capital held 2,993 positions worth $853M, up 5.1% from $812M the previous quarter. Its ten largest holdings account for 46% of the portfolio.

Lindbrook Capital's Q1 2023 filing shows 166 new, 1,040 increased, 961 reduced and 220 closed positions. Its largest new stake was Hess Midstream: 4,984 shares worth $144K. The largest sale was Oramed Pharmaceuticals, an estimated $4.61M.

By sector, the portfolio is most concentrated in Financials at 17% of assets, down from 18% a quarter earlier, followed by Technology and Healthcare.

  • Lindbrook Capital's largest Q1 2023 buy was Hess Midstream: 4,984 shares worth $144K.
  • Lindbrook Capital added most to Vanguard Total International Stock ETF in Q1 2023, an estimated $12.7M increase.
  • Lindbrook Capital's biggest Q1 2023 reduction was Agenus, cutting an estimated $2.89M.
  • Lindbrook Capital fully exited Oramed Pharmaceuticals in Q1 2023, selling an estimated $4.61M.
  • Lindbrook Capital's ten largest holdings make up 46% of its $853M portfolio in Q1 2023.
  • Lindbrook Capital opened 166 new positions and closed 220 in Q1 2023.
  • Lindbrook Capital's portfolio value rose 5.1% quarter-over-quarter to $853M.

Based on Lindbrook Capital's 13F filing for Q1 2023, filed 26 Apr 2023.